Direct accesses
Go to main menu
Go to main content
Menu
Search the site
Contact
Careers
You are viewing the website in English
en
fr
Search the site
Who
we are
Company
Leadership
Collaborations
Our products
& pipeline
Diseases we target
GS010 for LHON
GS030 for Retinitis Pigmentosa
GS030 for Geographic Atrophy in Dry-AMD
Our
technologies
Technologies we are applying
Gene Therapy
Mitochondrial Targeting Sequence (MTS)
Optogenetics
Investors
& media
Company Overview
Press releases
Events & presentations
News and press coverage
Stock information
Governance
Documentation
Documentation
Home
>
Investors & media
>
Documentation
Year
All
2022
2021
2020
2019
2018
2017
2016
Documentation type
All
Financial statements and reports
Regulated information
Corporate presentations
General meetings
09 May 2022
Corporate presentations
Corporate Presentation – May 2022
Open in new window
09 May 2022
General meetings
Convening Notice – 2022 General Meeting
Open in new window
04 May 2022
General meetings
Auditors’ report on 2021 consolidated Financial Statements in accordance with IFRS
Open in new window
04 May 2022
General meetings
Auditors’ report on 2021 Financial Statements in accordance with French Gaaps
Open in new window
04 May 2022
General meetings
Auditors’ special report on 2021 related party agreements
Open in new window
04 May 2022
General meetings
Auditors’ report on resolution number 29
Open in new window
04 May 2022
General meetings
Auditors’ report on resolution number 28
Open in new window
04 May 2022
General meetings
Auditors’ report on resolution number 27
Open in new window
04 May 2022
General meetings
Auditors’ report on resolutions number 20 to 26 and 30
Open in new window
04 May 2022
General meetings
Auditors’ report on resolution number 19
Open in new window
1
2
3
4
5
6
…
13
View next 9 articles
Go back to the page of the page